Imaging study for suspicious breast findings
Part of Cancer, Skin clinical trials.
This study looks at how detailed breast imaging can help diagnose breast cancer when a mammogram is suspicious. If your mammogram result was “highly suspicious” and you have not had a biopsy yet, the trial may be able to use your images to improve future diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You recently had a diagnostic mammogram that was labeled BI-RADS 4 or 5
- Your BI-RADS 4 means a suspicious abnormality, and BI-RADS 5 means highly suggestive of cancer
- You have not had a breast biopsy yet
- You are not pregnant and not breastfeeding
- You do not have a prior history of breast cancer or a mastectomy with systemic treatment (like chemotherapy or hormone-blocking pills)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether features seen on ultrasound and mammogram can help identify the molecular type of breast cancer. It may help patients understand their cancer better without extra tests.
This study tests a new type of mammogram that might give clearer pictures of breast tissue. It is for women who are either scheduled for breast surgery or getting a regular mammogram.
This trial compares different imaging schedules after breast-conserving surgery for people with a higher risk of recurrence. It tests whether more frequent or different types of scans can catch any return of cancer earlier.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
This study uses a special type of mammogram with contrast dye to see if it can predict how well breast cancer responds to chemotherapy before surgery. It's for people with HER2-positive or triple-negative breast cancer.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.